Hutchison MediPharma Limited's growth forecast was compared to the UK Pharma industry in August 2025.
1 report, 1 independent
Updated Aug 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Hutchison MediPharma Limited's growth forecast was compared to the UK Pharma industry in August 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hutchison MediPharma Limited
biopharmaceutical company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Simply Wall St.HUTCHMED (China) First Half 2025 Earnings: EPS: US$0.53 (vs US$0.03 in 1H 2024) Explore HUTCHMED (China)'s Fair Values from the Community and select yours Revenue: US$277.7m (down 9.2% from 1H 2024)